IDL Diagnostics AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. Its products include AroCell TK 210 ELISA, which was designed for simple, robust, and scalable measurement of Thymidine Kinase 1 in blood samples. The company was founded by Karl Axel Staffan Eriksson, Arne Ferstad, Qi Min He, Per Nils Jesper Matsson, Sven Skog, and Bernhard Tribukait in 2003 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
20
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. AroCell market cap is $85.91M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. AroCell 52 week high is $0.38 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AroCell 52 week low is $0.3729 as of November 18, 2026.
AroCell stock price today is $0.3729.
AroCell stock price yesterday was $0.37.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. AroCell's P/E ratio is -6.91.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. AroCell P/B ratio is 3.5198.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. AroCell 50-day moving average is $0.3729.